Bausch & Lomb opens new pharmaceutical headquarters

Madison, NJ

-Bausch & Lomb has opened a new 30,000-square-foot global pharmaceutical headquarters building in Madison, NJ. The company maintains its worldwide headquarters in Rochester, NY, and has research and development functions in locations around the world.

Bausch & Lomb said that its decision to locate the pharmaceutical facility in New Jersey stemmed from the fact that the state is the home to world or North American headquarters or significant operations of 15 of the world’s top 25 pharmaceutical companies.

“Establishing our global pharmaceutical headquarters in New Jersey opens up opportunities to partner with other pharmaceutical companies and to drive commercialization of new products. Our recently announced co-promotion agreement with Pfizer for prescription ophthalmics in the United States is the first example of how we are successfully implementing this strategy,” said Gerald M. Ostrov, chairman and chief executive officer of the company.

Flemming Ornskov, MD, MPH, MBA, global president of Bausch & Lomb's pharmaceutical business, said, “As we bring new products to market, such as our recently FDA-approved [besifloxacin ophthalmic suspension 0.6% (Besivance)] for the treatment of bacterial conjunctivitis, having our global and U.S. leadership, marketing, and sales teams headquartered in New Jersey is ideal. Not only does it provide professional development opportunities for current staff, but it is also fertile ground for recruiting the best possible talent to work with us, whether as an industry partner or employee.”

Seventy new full-time jobs will be created at the facility, according to the company.